@FiercePharma: Pfizer tuberculosis drug hits FDA shortage list, with other TB remedies already scarce. Story | Follow @FiercePharma
@EricPFierce: Momenta's Kaundinya doesn't mind some regulatory chaos in biosimilars. It allows industry to help shape pathway. Special Report | Follow @EricPFierce
> Roche's ($RHHBY) Avastin was again rebuffed by the U.K.'s cost-effectiveness watchdogs as a treatment for ovarian cancer. Report
> Pfizer ($PFE) won Japanese approval for its new rheumatoid arthritis drug Xeljanz, which got the FDA's thumbs up in November. Report
> Actavis won FDA approval for its version of the Reckitt Benckiser opioid dependency drug Suboxone, despite the branded maker's attempts to block it. Report
> Johnson & Johnson ($JNJ) recalled 1.9 million blood-sugar meters after a patient died after an inaccurate reading. Report
> Novartis ($NVS) sold its chemo-toxicity fighter Cardioxane to Clinigen, which believes it can revitalize the drug, for $33 million. Report
> South Africa's Cipla Medpro said its fiscal year earnings dropped 32%, despite a 30% increase in revenue to R2,297 billion, or about $248 million. Report
@FierceMedDev: Merck IUD lot hit with Hong Kong recall. Report | Follow @FierceMedDev
@MarkHFierce: A multi-gene sequencing cancer Dx test is hitting the U.K. health system, thanks to the NHS. More | Follow @MarkHFierce
@DamianFierce: Researchers at the Cleveland Clinic are developing a breath-based diagnostic to detect heart failure. Story | Follow @DamianFierce
> PrimeraDx teams with Quest for companion diagnostics. More
> TriReme allies with major China distributor for PAD devices. Story
> J&J recalls LifeScan glucose meters over shutdown risk. Report
Biotech News
@FierceBiotech: From FierceBiotechResearch.com: Researchers find possible cause of neuron dysfunction in Alzheimers. Article | Follow @FierceBiotech
@JohnCFierce: Another one bites the dust: Phytopharm slashes staff, scouts buyers after Parkinson's drug failure. Story | Follow @JohnCFierce
@RyanMFierce: The top 10 moneymakers in Pharma, ordered by revenue and described in context: More | Follow @RyanMFierce
> PRACS' CRO implosion leaves a Who's Who of biopharma creditors in its wake. Story
> Headed into PhIII, Lundbeck scores $825M Alzheimer's drug pact with Otsuka. Report
> Ziopharm sharpens budget ax after cancer drug palifosfamide flops in PhIII. News
Pharma Manufacturing News
> FDA fast-tracks plant for injectable on shortage list. More
> India state ups effort to root out counterfeits. Story
> Form 483 lays out latest issues dragging down Hospira. Report
> Sanofi, Transgene split cost of specialized manufacturing. Article
> Actavis puts $40M into Florida plant. More
Biotech Research News
@EmilyMFierce: Could a canker sore treatment be the next weight-loss drug? More | Follow @EmilyMFierce
> UMD scientists test new bird flu vaccine in animals. Report
> Astellas strikes deals to hunt for dengue fever therapies. More
> New database could be a boon for genomics research. Story
> Tiny wireless sensor moves brain research forward. Item
And Finally... Tufts University microbiologists identified the resistance mechanisms E. coli use to defy carbapenem antibiotics. Report